Literature DB >> 2539514

Retrovirus protease characterized as a dimeric aspartic proteinase.

I Katoh1, Y Ikawa, Y Yoshinaka.   

Abstract

Retroviruses and retroviruslike elements have a protease for specific cleavage of their polyprotein precursors. On the basis of amino acid sequences conserved among species and the sensitivity to protease inhibitors, it was proposed that the retrovirus protease could be classified as an aspartic proteinase. Since the virus protease molecule is comparable to a single domain of aspartic proteinases having two symmetrical domains, we hypothesized and examined the dimer formation of the protease. The results of biochemical molecular mass determination and cross-linking experiments demonstrated that the virus protease molecules self-assemble into dimers. An inhibitory effect of fragmented protease molecules suggests the possibility that the intermolecular association is required for their activity. Other experiments of chemical inactivation suggest a close resemblance of the catalytic features of retrovirus and aspartic proteinases. Characterizations of these bovine and avian virus proteases would provide basic knowledge for the design of retrovirus protease-specific inhibitors, which is one of the possible strategies against human immunodeficiency virus infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2539514      PMCID: PMC250640     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Structural evidence for gene duplication in the evolution of the acid proteases.

Authors:  J Tang; M N James; I N Hsu; J A Jenkins; T L Blundell
Journal:  Nature       Date:  1978-02-16       Impact factor: 49.962

2.  Silver staining of proteins in polyacrylamide gels.

Authors:  W Wray; T Boulikas; V P Wray; R Hancock
Journal:  Anal Biochem       Date:  1981-11-15       Impact factor: 3.365

3.  Nearest neighbor relationships of major structural proteins within bovine leukemia virus particles.

Authors:  W Uckert; P Westermann; V Wunderlich
Journal:  Virology       Date:  1982-09       Impact factor: 3.616

4.  Amino acid sequence of mouse submaxillary gland renin.

Authors:  K S Misono; J J Chang; T Inagami
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

5.  Characterization of the active site of mouse submaxillary gland renin.

Authors:  K S Misono; T Inagami
Journal:  Biochemistry       Date:  1980-06-10       Impact factor: 3.162

6.  Structural studies of retroviruses: characterization of oligomeric complexes of murine and feline leukemia virus envelope and core components formed upon cross-linking.

Authors:  A Pinter; E Fleissner
Journal:  J Virol       Date:  1979-04       Impact factor: 5.103

7.  p65 of Gazdar murine sarcoma viruses contains antigenic determinants from all four of the murine leukemia virus (MuLV) gag polypeptides (p15, p12, p30, and p10) and can be cleaved in vitro by the MuLV proteolytic activity.

Authors:  Y Yoshinaka; R B Luftig
Journal:  Virology       Date:  1982-04-30       Impact factor: 3.616

8.  Properties of a P70 proteolytic factor of murine leukemia viruses.

Authors:  Y Yoshinaka; R B Luftig
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

9.  Physicochemical characterization and specificity of the murine leukaemia virus Pr65gag proteolytic factor.

Authors:  Y Yoshinaka; R B Luftig
Journal:  J Gen Virol       Date:  1980-06       Impact factor: 3.891

10.  Amino acid sequence of p15 from avian myeloblastosis virus complex.

Authors:  R T Sauer; D W Allen; H D Niall
Journal:  Biochemistry       Date:  1981-06-23       Impact factor: 3.162

View more
  15 in total

1.  Properties of avian retrovirus particles defective in viral protease.

Authors:  L Stewart; G Schatz; V M Vogt
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

2.  Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites.

Authors:  T J Chambers; A Grakoui; C M Rice
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

3.  Analysis of deletions and thermosensitive mutations in Rous sarcoma virus gag protein p10.

Authors:  P Dupraz; P F Spahr
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

4.  Incorporation of chimeric gag protein into retroviral particles.

Authors:  R A Weldon; C R Erdie; M G Oliver; J W Wills
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

5.  Importance of the N terminus of rous sarcoma virus protease for structure and enzymatic function.

Authors:  G W Schatz; J Reinking; J Zippin; L K Nicholson; V M Vogt
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

6.  Potent inhibition of human immunodeficiency virus type 1 (HIV-1) replication by inducible expression of HIV-1 PR multimers.

Authors:  S J Arrigo; K Huffman
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

7.  Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins.

Authors:  C Failla; L Tomei; R De Francesco
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  Effect of linker insertion mutations in the human immunodeficiency virus type 1 gag gene on activation of viral protease expressed in bacteria.

Authors:  J Luban; C Lee; S P Goff
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

9.  Amino acids encoded downstream of gag are not required by Rous sarcoma virus protease during gag-mediated assembly.

Authors:  R P Bennett; S Rhee; R C Craven; E Hunter; J W Wills
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

10.  Human T-cell leukemia virus type 1 protease protein expressed in Escherichia coli possesses aspartic proteinase activity.

Authors:  A Saiga; T Tanaka; S Orita; A Sato; S Sato; T Hachisu; K Abe; Y Kimura; Y Kondo; T Fujiwara
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.